Pro-MP for Androgenetic Alopecia

About ProTransit Nanotherapy

ProTransit Nanotherapy is developing the Pro-MP™ platform, a nanotechnology-based sustained-release drug delivery system. The core innovation involves microparticles that can penetrate biological barriers and release therapeutics locally for up to 192 hours, aiming to improve efficacy while minimizing systemic side effects. Early data highlighted on its website suggests promising applications in cosmetic dermatology (reducing wrinkles, improving skin quality) and androgenetic alopecia (hair regrowth), with potential for broader therapeutic use. The company is a private, likely pre-revenue entity building on over a decade of academic research.

Therapeutic Areas